JUVMO, JUVMO (COPACKAGED)
ABBVIE · TAVAPADON
Open FDA's page for this record- Application number
- NDA220415
- Sponsor name
- ABBVIE
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20260925
- Review priority
- STANDARD
- Submission class code
- TYPE 1
- Submission class code description
- Type 1 - New Molecular Entity
- Application docs
- ID
- 87314
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/220415Orig1s000ltr.pdf
- Date
- 20260929
- Type
- Letter
- ID
- 87353
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/220415Orig1s000lbl.pdf
- Date
- 20261006
- Type
- Label
- Products
- Product number
- 004
- Reference drug
- Yes
- Brand name
- JUVMO
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Active ingredients
- Name
- TAVAPADON
- Strength
- 15MG
- Product number
- 002
- Reference drug
- Yes
- Brand name
- JUVMO
- Reference standard
- Yes
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Active ingredients
- Name
- TAVAPADON
- Strength
- 5MG
- Product number
- 005
- Reference drug
- No
- Brand name
- JUVMO
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Active ingredients
- Name
- TAVAPADON
- Strength
- 15MG
- Product number
- 003
- Reference drug
- Yes
- Brand name
- JUVMO
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Active ingredients
- Name
- TAVAPADON
- Strength
- 10MG
- Product number
- 001
- Reference drug
- Yes
- Brand name
- JUVMO (COPACKAGED)
- Reference standard
- Yes
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Active ingredients
- Name
- TAVAPADON
- Strength
- 0.25MG
